StockNow
Log in
U.S. Markets

US PRE-MARKET MOVERS: AZN, CIBR, U, AGX, TRIP

News detail

ES -0.4% NQ -0.6% RTY -0.6% AZN +3.6%: Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials CIBR -2.4%: Reports emerge of leaked Anthropic AI model, "Claude Mythos"; co. believes it poses unprecedented cybersecurity risks U +14.1%: Raised Q1 revenue view; PT raised at BofA AGX +9.5%: Earnings beat; upgraded at JPM to 'Overweight' from 'Neutral' TRIP +3.8%: Upgraded at BofA to 'Buy' from 'Neutral'

5 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYGeopolitics

Pakistani sources say Pakistan PM Sharif and Army Chief Munir will visit Saudi Arabia tomorrow, Al Hadath reports

U.S. Economy

US ADP Employment Change (Jul) 44K vs. Exp. 70K (Prev. 98K)